Lufax Holding Ltd is not a good buy at this time for a beginner, long-term investor. The company is facing significant legal and operational challenges, as evidenced by multiple class action lawsuits and internal control issues. Additionally, the financial performance shows declining revenue and negative EPS, which are not favorable for long-term growth. While technical indicators show some short-term bullish momentum, the lack of strong positive catalysts and the high-risk environment make this stock unsuitable for the given investor profile.
The MACD histogram is positive and expanding, indicating short-term bullish momentum. RSI is at 72.332, which is neutral but approaching overbought territory. Moving averages are converging, showing no clear trend. Key resistance is at 2.07 and 2.148, while support levels are at 1.818 and 1.74.

Short-term technical indicators suggest some bullish momentum. The stock has a 15.81% chance of gaining in the next month based on historical candlestick patterns.
Multiple class action lawsuits and allegations of internal control deficiencies. Removal of the auditor due to undisclosed related-party transactions. Declining revenue and negative EPS. No significant hedge fund or insider activity.
In Q4 2024, revenue dropped by -12.52% YoY to $6.03 billion. Net income improved but remains negative at -$1.33 billion, up 44.69% YoY. EPS dropped to -0.77, down -3.75% YoY. Gross margin remained unchanged at 0%.
No recent analyst ratings or price target changes available.